Medicenna Therapeutics Corp.
Financial ratios & Valuation

Forward Multiples (2026 – 2027)

20262027
Price/Earnings ratio
-0.62-0.51
Price/Sales ratio
N/AN/A
Earnings per Share (EPS)
$-0.25$-0.30

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-202.58-213.65-140.31-26.56-6.65-4.07-13.76-14.81-3.8335.63-5.60-6.65
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-580.91-9.20K83.3830.4522.967.323.166.674.161.861.587.32
Price/Cash Flow ratio
-250.43-202.28-72.81-27.74-4.90-2.38-12.77-16.62-3.68-4.35-3.96-4.90
Price/Free Cash Flow ratio
-250.43-201.79-72.81-27.72-4.90-2.38-12.77-16.62-3.68-4.35-3.96-4.90
Price/Earnings Growth ratio
N/A-24.39-2.49-0.060.210.09-0.30-0.42-0.19-0.330.180.18
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
0.49%N/A-0.03%-0.00%-0.54%-0.40%-0.38%0.61%-0.30%115.39%N/A-0.54%
Return on Assets
-136.05%-305.79%-23.18%-52.69%-170.65%-90.75%-21.86%-40.66%-96.54%4.24%-24.61%-170.65%
Return On Equity
286.75%4308.79%-59.42%-114.63%-345.33%-179.93%-22.98%-45.04%-108.69%5.24%-35.47%-345.33%
Return on Capital Employed
285.34%4295.00%-53.43%-107.45%-295.37%-169.37%-22.67%-45.05%-107.03%-49.93%-46.77%-295.37%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A12.75N/A
Quick Ratio
0.670.921.611.952.282.1320.8510.268.929.5712.152.28
Cash ratio
0.000.431.521.912.090.9812.507.397.838.8412.092.09
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A0.25N/AN/AN/A0.000.00N/AN/A0.12N/A
Debt Equity Ratio
N/AN/A0.64N/AN/AN/A0.000.00N/AN/A0.14N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.00N/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/A0.39N/AN/AN/A0.000.00N/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-30.42N/A
Cash Flow to Debt Ratio
N/AN/A-1.76N/AN/AN/A-133.02-450.32N/AN/AN/AN/A
Company Equity Multiplier
-2.10-14.092.562.172.021.981.051.101.121.231.141.98
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
11.0011.0011111111
Cash Flow Coverage Ratio
N/AN/A-1.76N/AN/AN/A-133.02-450.32N/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/A-1.76N/AN/AN/A-253.34-450.32N/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A